東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Innovation and Development Strategy of the Pharmaceutical Industry in China.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Innovation and Development Strategy of the Pharmaceutical Industry in China./
Author:	Yao, Dongning.
Description:	1 online resource (120 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 82-08, Section: B.
Contained By:	Dissertations Abstracts International82-08B.
Subject:	Biomedical engineering. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28316857click for full text (PQDT)
ISBN:	9798569984145

Innovation and Development Strategy of the Pharmaceutical Industry in China.
Yao, Dongning.

Innovation and Development Strategy of the Pharmaceutical Industry in China. - 1 online resource (120 pages)

Source: Dissertations Abstracts International, Volume: 82-08, Section: B.

Thesis (Ph.D.)--University of Macau, 2020.

Includes bibliographical references

Background: Pharmaceutical products are essential for treating and preventing public from illness, and research and development (R&D) for new drugs is indispensable for keeping the whole industry consistently successful and efficient. How to keep the pharmaceutical innovation energetic and sustainable is one of the main challenges worldwide. Such challenges also occur in China during the development of our domestic pharmaceutical industry. But few researches have been found on focusing to study the domestic pharmaceutical innovation systematically.Objectives: This project aimed to: (1) systematically provide a review of the current development and the achievement accomplished of pharmaceutical industry in mainland China; (2) explore the perceptions and opinions from the key stakeholders to form a comprehensive view of the progresses, barriers of domestic pharmaceutical industry; (3) illustrate the possible solution and policy recommendations for improving and promoting the further development of pharmaceutical innovation of the domestic pharmaceutical industries.Methodology: The innovation system analysis (IS) was used. The documentary analysis and quantitative data were analyzed by the main components of IS. Eight semi-structure interviews were conducted to collect qualitative results for the functional analysis.Results: This project analyzed the development of domestic pharmaceutical industry in the past decade followed by the IS analysis, the 3 main components in the IS were identified. The 7 functions in the IS were discussed respectively under the results of semi-structure interview.Conclusions: This project provided a comprehensive view of the development and innovation of domestic pharmaceutical industry. The progresses which have been made, and the barriers hindering the pharmaceutical innovation were identified. The output of this research will be valuable for the policymakers in the related field to consider the future development in this sector.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798569984145Subjects--Topical Terms:

535387
Biomedical engineering.
Subjects--Index Terms:

ChinaIndex Terms--Genre/Form:

542853
Electronic books.

Innovation and Development Strategy of the Pharmaceutical Industry in China.
LDR:03310nmm a2200373K 4500 001 2365092
005 20231213130539.5
006 m o d
007 cr mn ---uuuuu
008 241011s2020 xx obm 000 0 eng d
020 $a 9798569984145
035 $a (MiAaPQ)AAI28316857
035 $a AAI28316857
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Yao, Dongning. $3 3705912
245 1 0 $a Innovation and Development Strategy of the Pharmaceutical Industry in China.
264 0 $c 2020
300 $a 1 online resource (120 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 82-08, Section: B.
500 $a Advisor: Wang, Yitao;Hu, Yuanjia.
502 $a Thesis (Ph.D.)--University of Macau, 2020.
504 $a Includes bibliographical references
520 $a Background: Pharmaceutical products are essential for treating and preventing public from illness, and research and development (R&D) for new drugs is indispensable for keeping the whole industry consistently successful and efficient. How to keep the pharmaceutical innovation energetic and sustainable is one of the main challenges worldwide. Such challenges also occur in China during the development of our domestic pharmaceutical industry. But few researches have been found on focusing to study the domestic pharmaceutical innovation systematically.Objectives: This project aimed to: (1) systematically provide a review of the current development and the achievement accomplished of pharmaceutical industry in mainland China; (2) explore the perceptions and opinions from the key stakeholders to form a comprehensive view of the progresses, barriers of domestic pharmaceutical industry; (3) illustrate the possible solution and policy recommendations for improving and promoting the further development of pharmaceutical innovation of the domestic pharmaceutical industries.Methodology: The innovation system analysis (IS) was used. The documentary analysis and quantitative data were analyzed by the main components of IS. Eight semi-structure interviews were conducted to collect qualitative results for the functional analysis.Results: This project analyzed the development of domestic pharmaceutical industry in the past decade followed by the IS analysis, the 3 main components in the IS were identified. The 7 functions in the IS were discussed respectively under the results of semi-structure interview.Conclusions: This project provided a comprehensive view of the development and innovation of domestic pharmaceutical industry. The progresses which have been made, and the barriers hindering the pharmaceutical innovation were identified. The output of this research will be valuable for the policymakers in the related field to consider the future development in this sector.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Biomedical engineering. $3 535387
650 4 $a Public health. $3 534748
650 4 $a Pharmacology. $3 634543
653 $a China
653 $a Innovation System analysis
653 $a Pharmaceutical industry
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0541
690 $a 0419
690 $a 0573
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a University of Macau. $b Chinese Medical Sciences. $3 3560130
773 0 $t Dissertations Abstracts International $g 82-08B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28316857 $z click for full text (PQDT)